Skip to main content
Top
Published in: International Urology and Nephrology 1/2012

01-02-2012 | Urology – Original Paper

Size of the transrectal ultrasound probe makes no difference in pain perception during TRUS-Bx under adequate local anesthesia

Authors: Sefik Koprulu, Ibrahim Cevik, Nuri Unlu, Ozdal Dillioglugil

Published in: International Urology and Nephrology | Issue 1/2012

Login to get access

Abstract

Introduction and objectives

In the great majority of the cases, transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the definitive step in the diagnosis of prostate cancer (CaP). Although this procedure is well tolerated by most patients, it can result in considerable discomfort that can effectively be overcome with local injection anesthesia. In this study, we evaluated the effect of the size (i.e., circumference) of the transrectal probe on pain during TRUS-Bx.

Material and methods

One hundred and seventy eligible patients who had elevated total prostate specific antigen (tPSA) and/or abnormal digital rectal examination (DRE) were included in this study. Patients (pts.) were divided into three TRUS-Bx groups; Group I: 60 pts. underwent TRUS-Bx with newer B–K Type 8808 probe (circumference 58 mm) under injectable periprostatic anesthesia, Group II: 60 pts. underwent TRUS-Bx with B–K Type 8551 probe (circumference 74 mm) under injectable periprostatic anesthesia, and Group III: 50 pts. underwent TRUS-Bx with B–K Type 8551 probe (circumference 74 mm) without local anesthesia. Periprostatic injection anesthesia was performed with 10 cc, 1% lidocaine (5 cc on each side) 10 min before TRUS-Bx. Pain was assessed using a 10-point modified visual analog scale (VAS) 15 min after the biopsy procedure.

Results

Three groups were homogeneous with respect to age and tPSA, and no statistically significant difference was observed in terms of mean biopsy duration between the 3 groups. Most of the patients experienced no pain to slight pain in Groups I and II, but 66% of the patients had more than moderate pain (VAS ≥ 5) in Group III with mean VAS score statistically higher than the other two groups (Group I vs. III, P = 0.0001; Group II vs. III, P = 0.0001). Mean VAS score was not statistically different between Group I and II (P = 0.126). No statistically significant difference in VAS pain perception was observed between different age categories within the Group I, II, and III.

Conclusion

In the absence of injectable local anesthesia, larger probe (74 mm) results in much higher VAS pain perception than same size and smaller (58 mm) probe used under injectable local anesthesia. However, under injectable local anesthesia, the size (circumference) of the transrectal probe (58 mm vs. 74 mm) does not result in any different pain perception during TRUS-Bx.
Literature
1.
go back to reference Issa MM, Bux S, Chun T et al (2000) A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: The Emory University experience. J Urol 164:397–399PubMedCrossRef Issa MM, Bux S, Chun T et al (2000) A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: The Emory University experience. J Urol 164:397–399PubMedCrossRef
2.
go back to reference Irani J, Fournier F, Bon D et al (1997) Patient tolerance of transrectal ultrasound guided biopsy of the prostate. Br J Urol 79:608PubMedCrossRef Irani J, Fournier F, Bon D et al (1997) Patient tolerance of transrectal ultrasound guided biopsy of the prostate. Br J Urol 79:608PubMedCrossRef
3.
go back to reference Leibovici D, Zisman A, Siegel YI et al (2002) Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled study. J Urol 167:563–565PubMedCrossRef Leibovici D, Zisman A, Siegel YI et al (2002) Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled study. J Urol 167:563–565PubMedCrossRef
4.
go back to reference Ozveri H, Cevik I, Dillioglugil O et al (2003) Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: as prospective study. Prostate Cancer Prostatic Dis 6:311–314PubMedCrossRef Ozveri H, Cevik I, Dillioglugil O et al (2003) Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: as prospective study. Prostate Cancer Prostatic Dis 6:311–314PubMedCrossRef
5.
go back to reference Cevik I, Dillioglugil O, Zisman et al (2006) Combined “periprostatic and peri-apical” local anesthesia is not superior to “periprostatic” anesthesia alone in reducing pain during tru-cut prostate biopsy. 68:1215–1219 Cevik I, Dillioglugil O, Zisman et al (2006) Combined “periprostatic and peri-apical” local anesthesia is not superior to “periprostatic” anesthesia alone in reducing pain during tru-cut prostate biopsy. 68:1215–1219
6.
go back to reference Inal G, Adsan O, Ugurlu O et al (2008) Comparison of four different anesthesia methods for relief of all pain during transrectal ultrasound guided prostate biopsy. Int Urol Nephrol 40:335–339PubMedCrossRef Inal G, Adsan O, Ugurlu O et al (2008) Comparison of four different anesthesia methods for relief of all pain during transrectal ultrasound guided prostate biopsy. Int Urol Nephrol 40:335–339PubMedCrossRef
7.
go back to reference Cevik I, Ozveri H, Dillioglugil O et al (2002) Lack of effect of intrarectal lidocaine for pain control during transrectal prostate biopsy: a randomized prospective study. Eur Urol 42:217–220PubMedCrossRef Cevik I, Ozveri H, Dillioglugil O et al (2002) Lack of effect of intrarectal lidocaine for pain control during transrectal prostate biopsy: a randomized prospective study. Eur Urol 42:217–220PubMedCrossRef
8.
go back to reference Naughton CK, Miller DC, Mager DE, et al A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388–392 Naughton CK, Miller DC, Mager DE, et al A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 164:388–392
9.
go back to reference Kandirali E, Ulukaradag E, Uysal B et al (2009) Is only anesthesia with lidocaine-prilocaine cream sufficient to decrease the pain during transrectal ultrasound-guided prostate biopsy? A prospective randomized study. Urol Int 82:262–265PubMedCrossRef Kandirali E, Ulukaradag E, Uysal B et al (2009) Is only anesthesia with lidocaine-prilocaine cream sufficient to decrease the pain during transrectal ultrasound-guided prostate biopsy? A prospective randomized study. Urol Int 82:262–265PubMedCrossRef
10.
go back to reference Pendleton J, Costa J, Wludyka P et al (2006) Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound-guided biopsy of the prostate. A prospective randomized controlled trial. J Urol 176:1372PubMedCrossRef Pendleton J, Costa J, Wludyka P et al (2006) Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound-guided biopsy of the prostate. A prospective randomized controlled trial. J Urol 176:1372PubMedCrossRef
11.
go back to reference Bozlu M, Atici S, Ulusoy E et al (2004) Periprostatic lidocaine infiltration and/or synthetic opioid (meperidine or tramadol) administration have no analgesic benefit during prostate biopsy. A prospective randomized, placebo-controlled study comparing different methods. Urol Int 72:308–311PubMedCrossRef Bozlu M, Atici S, Ulusoy E et al (2004) Periprostatic lidocaine infiltration and/or synthetic opioid (meperidine or tramadol) administration have no analgesic benefit during prostate biopsy. A prospective randomized, placebo-controlled study comparing different methods. Urol Int 72:308–311PubMedCrossRef
12.
go back to reference Bingqian L, Peihuan L, Yudong W et al (2009) Intraprostatic local anesthesia with periprostatic nerve block for transrectal ultrasound guided prostate biopsy. J Urol 182:479–484PubMedCrossRef Bingqian L, Peihuan L, Yudong W et al (2009) Intraprostatic local anesthesia with periprostatic nerve block for transrectal ultrasound guided prostate biopsy. J Urol 182:479–484PubMedCrossRef
13.
go back to reference Lee HY, Lee HJ, Byun SS et al (2007) Effect of intraprostatic local anesthesia during transrectal ultrasound guided prostate biopsy. Comparison of 3 methods in a randomized, double-blind placebo controlled trial. J Urol 178:469PubMedCrossRef Lee HY, Lee HJ, Byun SS et al (2007) Effect of intraprostatic local anesthesia during transrectal ultrasound guided prostate biopsy. Comparison of 3 methods in a randomized, double-blind placebo controlled trial. J Urol 178:469PubMedCrossRef
14.
go back to reference Cam K, Sener M, Kayikci A et al (2008) Combined periprostatic, intraprostatic local anesthesia for prostate biopsy: a randomized, double-blind placebo controlled study. J Urol 180:141PubMedCrossRef Cam K, Sener M, Kayikci A et al (2008) Combined periprostatic, intraprostatic local anesthesia for prostate biopsy: a randomized, double-blind placebo controlled study. J Urol 180:141PubMedCrossRef
Metadata
Title
Size of the transrectal ultrasound probe makes no difference in pain perception during TRUS-Bx under adequate local anesthesia
Authors
Sefik Koprulu
Ibrahim Cevik
Nuri Unlu
Ozdal Dillioglugil
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9993-y

Other articles of this Issue 1/2012

International Urology and Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine